100 related articles for article (PubMed ID: 12153171)
1. Prognostic value of Bcl 10 rearrangement in diffuse large B-cell lymphoma.
Kawasaki C; Ohshima K; Muta H; Muta K; Deyev V; Podack ER; Kikuchi M
Leuk Lymphoma; 2002 Apr; 43(4):823-6. PubMed ID: 12153171
[TBL] [Abstract][Full Text] [Related]
2. Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas.
Kawasaki C; Ohshim K; Suzumiya J; Kanda M; Tsuchiya T; Tamura K; Kikuchi M
Leuk Lymphoma; 2001; 42(5):1099-106. PubMed ID: 11697627
[TBL] [Abstract][Full Text] [Related]
3. Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients.
Vitolo U; Gaidano G; Botto B; Volpe G; Audisio E; Bertini M; Calvi R; Freilone R; Novero D; Orsucci L; Pastore C; Capello D; Parvis G; Sacco C; Zagonel V; Carbone A; Mazza U; Palestro G; Saglio G; Resegotti L
Ann Oncol; 1998 Jan; 9(1):55-61. PubMed ID: 9541684
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of bcl-2 (MBR)/JH rearrangement in the peripheral blood of patients with diffuse large B-cell lymphomas.
Zucca E; Bertoni F; Bosshard G; Roggero E; Ceresa E; Sanna P; Pedrinis E; Cavalli F
Ann Oncol; 1996 Dec; 7(10):1023-7. PubMed ID: 9037360
[TBL] [Abstract][Full Text] [Related]
5. bcl-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features.
Jacobson JO; Wilkes BM; Kwaiatkowski DJ; Medeiros LJ; Aisenberg AC; Harris NL
Cancer; 1993 Jul; 72(1):231-6. PubMed ID: 8508412
[TBL] [Abstract][Full Text] [Related]
6. High incidence of BCL-6 gene rearrangement in diffuse large B-cell lymphoma of primary gastric origin.
Liang R; Chan WP; Kwong YL; Xu WS; Srivastava G; Ho FC
Cancer Genet Cytogenet; 1997 Sep; 97(2):114-8. PubMed ID: 9283593
[TBL] [Abstract][Full Text] [Related]
7. [Long-term remission after CHOP therapy in a case of multifocal extranodal diffuse large B-cell lymphoma with t(1 ; 14) (p22 ; q32) and rearrangement of bcl-10].
Sakai R; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Oct; 46(10):1105-8. PubMed ID: 16440771
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma].
Xu FP; Liu YH; Luo XL; Zhuang HG; Li L; Luo DL; Xu J; Zhang F; Zhang MH; Du X; Li WY
Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):371-6. PubMed ID: 19031715
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of bcl-6 protein expression and gene rearrangement in diffuse large B-cell lymphoma].
Min DL; Xia HL; Zhou XY; Sun MH; Yang WT; Zhang TM; Zheng AH; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):327-31. PubMed ID: 16185497
[TBL] [Abstract][Full Text] [Related]
10. Bcl-6 gene hypermutations in diffuse large B-cell lymphoma of primary gastric origin.
Liang R; Chan WP; Kwong YL; Chan AC; Xu WS; Au WY; Srivastava G; Ho FC
Br J Haematol; 1997 Dec; 99(3):668-70. PubMed ID: 9401082
[TBL] [Abstract][Full Text] [Related]
11. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and prognosis of concurrent positive t(14; 18) and myc gene rearrangement in diffuse large B cell lymphoma].
Zhang HW; Chen ZW; Wang LY; He JX; Zheng YP; Han WE; Yang B; Wang YL; Zhao ZQ; Bai M; Su LP
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):206-10. PubMed ID: 26988827
[TBL] [Abstract][Full Text] [Related]
13. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas.
Pescarmona E; De Sanctis V; Pistilli A; Pacchiarotti A; Martelli M; Guglielmi C; Mandelli F; Baroni CD; Le Coco F
J Pathol; 1997 Nov; 183(3):281-6. PubMed ID: 9422982
[TBL] [Abstract][Full Text] [Related]
14. [bcl-2 gene in B cell lymphoma].
Seto M; Osada H
Rinsho Ketsueki; 1991 Jun; 32(6):644-9. PubMed ID: 1890741
[TBL] [Abstract][Full Text] [Related]
15. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma.
Offit K; Lo Coco F; Louie DC; Parsa NZ; Leung D; Portlock C; Ye BH; Lista F; Filippa DA; Rosenbaum A
N Engl J Med; 1994 Jul; 331(2):74-80. PubMed ID: 8208268
[TBL] [Abstract][Full Text] [Related]
16. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
17. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
18. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.
Katzenberger T; Ott G; Klein T; Kalla J; Müller-Hermelink HK; Ott MM
Am J Pathol; 2004 Aug; 165(2):481-90. PubMed ID: 15277222
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases.
Tang SC; Visser L; Hepperle B; Hanson J; Poppema S
J Clin Oncol; 1994 Jan; 12(1):149-54. PubMed ID: 8270971
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients.
Niitsu N; Okamoto M; Nakamura N; Nakamine H; Aoki S; Hirano M; Miura I
Leuk Res; 2007 Sep; 31(9):1191-7. PubMed ID: 17197022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
